Skip to main content
. 2012 Jan 10;153(3):1538–1547. doi: 10.1210/en.2011-1864

Table 3.

Incidence of IHC staining for RET, S6, and MEK phosphoproteins in C cells in CD-1 wild-type mice treated with liraglutide or vehicle for 13 wk

Treatment Positive IHC/total examined
pRET pMEK pS6
Liraglutide vehicle 0/12 0/12 0/11
Liraglutide, 3.0 mg/kg · d 0/12 0/12 10/11